Alphatec Holdings (ATEC) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.48% |
| Dec 31, 2025 | 45.11% |
| Sep 30, 2025 | -30.72% |
| Jun 30, 2025 | 59.73% |
| Mar 31, 2025 | 50.26% |
| Dec 31, 2024 | -29.98% |
| Sep 30, 2024 | 143.92% |
| Jun 30, 2024 | -30.12% |
| Mar 31, 2024 | 49.15% |
| Dec 31, 2023 | 69.54% |
| Sep 30, 2023 | 45.11% |
| Jun 30, 2023 | -27.23% |
| Mar 31, 2023 | 29.16% |
| Dec 31, 2022 | 55.28% |
| Sep 30, 2022 | -72.42% |
| Jun 30, 2022 | 45.09% |
| Mar 31, 2022 | 18.74% |
| Dec 31, 2021 | -49.83% |
| Sep 30, 2021 | 54.38% |
| Jun 30, 2021 | 64.89% |
| Mar 31, 2021 | 27.60% |
| Dec 31, 2020 | -133.35% |
| Sep 30, 2020 | 38.74% |
| Jun 30, 2020 | 32.23% |
| Mar 31, 2020 | 7.92% |
| Dec 31, 2019 | 27.02% |
| Sep 30, 2019 | -16.81% |
| Jun 30, 2019 | 13.60% |
| Mar 31, 2019 | -14.43% |
| Dec 31, 2018 | 61.90% |
| Sep 30, 2018 | 27.64% |
| Jun 30, 2018 | -18.36% |
| Mar 31, 2018 | -27.20% |
| Dec 31, 2017 | -29.80% |
| Sep 30, 2017 | 18.96% |
| Jun 30, 2017 | -6.00% |
| Mar 31, 2017 | -10.30% |
| Dec 31, 2016 | 52.86% |
| Sep 30, 2016 | -19.56% |
| Jun 30, 2016 | -28.50% |
| Mar 31, 2016 | 22.00% |
| Dec 31, 2015 | 13.45% |
| Sep 30, 2015 | 23.66% |